GlaxoSmithKline plc (NYSE:GSK) Q3 2021 Earnings Conference Call October 27, 2021 9:00 AM ET
Company Participants
Emma Walmsley – CEO
Nick Stone – Head of Investor Relations
Brian McNamara – CEO of GSK Consumer Healthcare
Iain Mackay – CFO
Hal Barron – Chief Scientific Officer
Roger Connor – President of GSK
David Redfern – Chief Strategy Officer
Deborah Waterhouse – CEO of ViiV Healthcare
Luke Miels – Chief Commercial Officer
Conference Call Participants
James Gordon – JP Morgan
Peter Holford – Jefferies
Mark Purcell – Morgan Stanley
Simon Martha – Exane
Graham Parry – Bank of America
Seamus Fernandez – Guggenheim
Andrew Baum – Citi
Laura Sutcliffe – UBS
Kerry Holford – Berenberg
Operator
Good afternoon, everyone and welcome to the analyst call on the GSK's Third Quarter 2021 Results. I will now hand you over to Nick Stone, Head of Investor Relations, who will introduce today's session.
Nick Stone
Thank you, Operator. And good morning and good afternoon. As you've just said, I am Nick Stone, Head of Investor Relations at GSK. It's my pleasure to welcome you to our third quarter 2020 conference call and webcast for investors. The presentation was posted to GSK.com and was also sent to our distribution list a little bit earlier today. Please turn to slide 2. This is usual safe harbor statements and will be making comments from performance using constant exchange rate or CR. Please turn to slide 3. This is today's agenda where we'll try to cover all aspects of our results.
The presentation will last approximately 25 minutes in order to maximize the opportunity to questions. For those on the phone, please join the queue by pressing star 1 and we request that you ask a maximum 2 questions so that everyone has a chance to participate. Our speakers today are Emma
- Read more current GSK analysis and news
- View all earnings call transcripts